Intelligo

Private limited company · Oslo

AGIANA PHARMACEUTICALS AS

ActiveResearch and experimental development on natural sciences and engineering (72.100)

Founded
20 May 2021
Chief executive
Rizwan Iqbal Hussain
Business address
Gaustadalléen 21, 0349 Oslo

The life line 2021–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 2.9m.

  1. Kapital§ 14
  2. Managing director took office§ 07
  3. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

AGIANA PHARMACEUTICALS AS is a private limited company in Oslo, founded in 2021, in the industry research and experimental development on natural sciences and engineering. The chief executive is Rizwan Iqbal Hussain, and the chair of the board is Thomas Ramdahl. In 2025 the company had NOK 2.9m in operating revenue and a net profit of NOK −15.2m. The largest owner is INVEN2 AS with 37.1%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 3 Jul 2026

  • Annual accounts filed 2024 → 2025
  • Godkjent årsregnskap
  • Endring av styre
  • Endring av kapital

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

1 point

  • NoteOperating loss three years running, 2023–2025

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 2.9m in 2025

Revenue

NOK 2.9m

+439.0% from 2024

20232025

Operating profit

NOK −15.5m

−231.6% from 2024

20232025

Net profit

NOK −15.2m

−237.0% from 2024

20232025

Equity

NOK 3.3m

−75.8% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Operating costs 636%

Costs exceeded revenue: the operating result was NOK −15.5m.

Source: the Register of Company Accounts, read 2 Nov 2026

Finances

§ 05 Financial health

Equity ratio 40.5%

RevenueNOK 2.9m Operating margin−536.3% Equity ratio40.5% Revenue growth+439.0%
  • AGIANA PHARMACEUTICALS AS, 2025
  • Industry median, assumed: NOK 1.5m · −4.4% · 48.9% · +3.0%

Equity NOK 3.3m41% of the assets (NOK 8.0m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 694 companies in 72.100 Research and experimental development on natural sciences and engineering, not stated by the source.

Finances

§ 06 Accounts

5 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue2,882535235
Operating profit−15,454−4,660−2,636
Profit before tax−15,168−4,501−2,946
Net profit−15,168−4,501−2,946
Total assets8,02714,1421,681
Equity3,25313,418−5,875
Liabilities4,7757247,556

Source: the Register of Company Accounts, read 15 Nov 2026 · All 5 years →

Management and ownership

§ 07 Officers

7 officers now

The board: 5 members

Source: the Brønnøysund Register Centre, read 9 Sep 2026 · All 7 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Styrets leder alene.

May sign for the company:

Styrets leder alene.

Power of procuration:

Styrets leder alene.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 4 Oct 2026

Management and ownership

§ 09 Owners

1 shareholder · largest 37.1%

OwnerShare
INVEN2 AS
37.1%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 1 owners →

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

11 connections

  • Person
  • Company

3 people link AGIANA PHARMACEUTICALS AS to 10 other companies: Thomas Ramdahl 5, Rizwan Iqbal Hussain 3 and Ken Roger Rosendal 2.

Source: the Brønnøysund Register Centre, read 9 Sep 2026 · Explore the network →

Events and registers

§ 13 Events

18 since 2021

Events per year

20212026

  • Notices17
  • Register changes1

Since 2021: 17 announcements and 1 register change. Most happened in 2022 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 1 Nov 2026. Register changes are Intelligo's own observations. · All 18 events →

Events and registers

§ 14 Notices

17, latest 1 Jul 2026

  • Godkjente årsregnskap
  • Styre
  • Kapital

Source: The Brønnøysund Register Centre's announcements ↗, read 1 Nov 2026 · All 17 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 3 Sep 2021
  • VATRegistered
  • The Register of Business EnterprisesRegistered 3 Sep 2021
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Utvikling og kommersialisering av legemidler.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 72.100

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

6 questions

  • Who is the chief executive of AGIANA PHARMACEUTICALS AS?
    Rizwan Iqbal Hussain, since 2022. § 07
  • Who owns AGIANA PHARMACEUTICALS AS?
    1 shareholder. It is INVEN2 AS with 37.1%. § 09
  • What was the revenue in 2025?
    NOK 2.9m in the company. § 06
  • Who can sign for AGIANA PHARMACEUTICALS AS?
    Styrets leder alene. § 08
  • Where is AGIANA PHARMACEUTICALS AS based?
    Gaustadalléen 21, 0349 Oslo.
  • When was AGIANA PHARMACEUTICALS AS founded?
    20 May 2021, registered in the Register of Business Enterprises 3 Sep 2021. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose